Cargando…
The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis
OBJECTIVES: To investigate the efficacy and safety of Bevacizumab (Bev) used in combination with paclitaxel and carboplatin (PC), compared with PC alone in patients with advanced non-small-cell lung cancer (NSCLC). MATERIALS AND METHODS: We searched the PubMed, EMBASE, Cochrane Central Register of C...
Autores principales: | Han, Shiqian, Hong, Yuanduo, Liu, Tingting, Wu, Na, Ye, Zhijia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865694/ https://www.ncbi.nlm.nih.gov/pubmed/29581868 http://dx.doi.org/10.18632/oncotarget.23657 |
Ejemplares similares
-
Efficacy and Safety of Bevacizumab in Pretreated Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
por: Li, Zhijun, et al.
Publicado: (2022) -
Efficacy and safety of laparoscopic pyelolithotomy versus
percutaneous nephrolithotomy for treatment of large renal stones: a
meta-analysis
por: Mao, Tie, et al.
Publicado: (2021) -
Trifluridine/tipiracil with or without bevacizumab in metastatic colorectal cancer: results of a systematic review and meta-analysis
por: Yoshino, Takayuki, et al.
Publicado: (2023) -
Comparative efficacy and safety of antibody induction therapy for the treatment of kidney: a network meta-analysis
por: Shao, Mingjie, et al.
Publicado: (2017) -
Efficacy and safety of immune checkpoint inhibitors for advanced non-small cell lung cancer with or without PD-L1 selection: A systematic review and network meta-analysis
por: Li, Yan, et al.
Publicado: (2023)